Brendan Plann-Curley

Mr. Brendan Plann-Curley

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2025 in Pancreatology
Verified
Journal Article
Open access
JMJorge D. Machicado
Jorge D. Machicado
STSamuel Tanner
Samuel Tanner
DADayyan Adoor
Dayyan Adoor
JCJean Chalhoub
Jean Chalhoub
BPBrendan Plann-Curley
Brendan Plann-Curley
FWField F. Willingham
Field F. Willingham
The efficacy of endoscopic ultrasound-guided celiac plexus block (EUS-CPB) for treatment of pain in chronic pancreatitis (CP) is unclear. Therefore, we aimed to assess this outcome using a systematic review and meta-analysis. We conducted a comprehensive search of MEDLINE, EMBASE, and Cochrane Central for evaluating the efficacy of EUS-CPB for pain in CP. We evaluated: A) overall efficacy of EUS-CPB (defined as proportion of patients with any pain relief); B) duration of pain relief; C) efficacy of EUS-CPB at 4, 8, 12, and 26 weeks post-procedurally; and D) adverse events. A proportional meta-analysis was performed using the logit transformation. Outcomes were pooled using a random-effects model. 11 studies encompassing 729 patients met inclusion and exclusion criteria. The overall efficacy of EUS-CPB was 53% (95% CI 39-67%, I2 = 91%). The mean duration of pain relief was 81 days (95% CI 30-217, I2 = 96%). The efficacy of EUS-CPB at 4 weeks was 52% (95% CI 22-81%, I2 = 90%), at 8 weeks was 57% (95% CI 48-66%, I2 = 0%), at 12 weeks was 19% (95% CI 12-27%, I2 = 68%), and at 26 weeks was 3% (95% CI 1-8%, I2 = 0%). The prevalence of adverse events was 8% (95% CI 4-15%, I2 = 67%). EUS-CPB provides pain relief in 53% of patients with painful CP and the effect lasts on average for 3 months. A sham-controlled clinical trial is needed to determine the analgesic efficacy of EUS-CPB for pain in CP.

17 November 2025 in Dermatopathology
Verified
Journal Article
Open access
PDF file
SOSumeyye Ozer
Sumeyye Ozer
PAPriya Agarwal
Priya Agarwal
NMNoah Musolff
Noah Musolff
BPBrendan Plann-Curley
Brendan Plann-Curley
GCGizem Cosgun
Gizem Cosgun
BRBabar Rao
Babar Rao
Melanoma is a highly aggressive skin cancer primarily linked to ultraviolet (UV) radiation. However, the potential role of ionizing radiation from radiotherapy in melanoma development remains unclear. This review synthesizes data from epidemiologic studies and case reports on melanoma after radiation exposure. Evidence indicates that childhood radiotherapy, even at low doses, is associated with an increased melanoma risk, plausibly reflecting the heightened radiosensitivity of developing melanocytes. Occupational radiation exposure, particularly in earlier eras with insufficient shielding, also appears to elevate risk. In patients exposed to radiation in adulthood, findings are mixed: large population datasets suggest a modest increase in melanoma following therapeutic radiation, whereas some case–control analyses do not demonstrate a clear dose–response relationship. UV radiation promotes melanomagenesis through direct DNA photoproducts driving characteristic C>T transitions at dipyrimidine sites, alongside oxidative stress and local immune modulation that facilitate malignant transformation. Collectively, individuals with prior radiotherapy, especially those irradiated in childhood, should be considered at increased melanoma risk and may benefit from long-term, targeted surveillance of irradiated fields. Awareness of this association between radiation exposure and melanoma may also support clinicopathologic correlation during the diagnostic evaluation of melanocytic lesions. Future work should define dose–response relationships in contemporary radiotherapy methods, characterize molecular signatures of ionizing radiation-associated melanomas, and establish evidence-based surveillance strategies for high-risk cohorts.

Verified
Journal Article
Open access
PDF file
OAOmar Abureesh
Omar Abureesh
WSWalid Sange
Walid Sange
QZQusai Al Zureikat
Qusai Al Zureikat
THToni Habib
Toni Habib
MAMohammad Abu-shaban
Mohammad Abu-shaban
Liliane DeebLiliane Deeb
Liliane Deeb
Background: Gastroesophageal reflux disease (GERD) is a common problem that affects patients. The constant irritation of the esophageal mucosa, in addition to the potential aspiration, has been suggested as a predisposing factor for lung cancer (LC). This study aims to investigate the association between GERD and LC. Methods: An electronic search was conducted on EMBASE, CENTRAL, and PubMed databases from inception through November 2025. Studies evaluating the association between GERD and lung cancer in adult populations were included. Reviews, non-English articles, pediatric studies, and non-human studies were excluded. Twelve studies involving 2,900,965 patients met the inclusion criteria. Three types of common and random effect meta-analyses were utilized, namely meta-analysis of proportion, log(HR) and log(OR) models. Included studies were examined for risk of bias using the Newcastle–Ottawa scale. Results: Twelve articles describing 2,900,965 patients were found to be fit for inclusion. Male and female sexes were equally represented. On average, patients were 57.67 ± 10.02 years of age. Pooled proportion of co-occurring LC and GERD in patients was estimated at 64% [95% C.I.: 15–95%; p = 0.02], with significant heterogeneity (I2 = 96.8%, p < 0.01). Among studies calculating for hazard ratio (HR), an estimated pooled log(HR) of 1.01 [95% C.I.: 0.36–2.8; p = 0.98] with significant data heterogeneity (I2 = 88%, p < 0.01) was found. In comparison, five studies included estimates of odds ratio (OR), which resulted in a pooled log(OR) of 1.32 [95% C.I.: 1.2–1.46; p < 0.01], with less heterogeneity (I2 = 59.1%) which was marginally significant (p = 0.04). Conclusions: Our findings may suggest a possible association between LC and GERD; however, estimates were discordant across effect measures and heterogeneity was substantial, so this association should be interpreted with caution.

10 December 2025 in Journal of Hospital Librarianship
Verified
Journal Article
Closed access
LBLena Bohman
Lena Bohman
BPBrendan Plann-Curley
Brendan Plann-Curley
RVRegina Vitiello
Regina Vitiello